Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

L Elkrief, V Hernandez-Gea, M Senzolo… - The lancet …, 2024 - thelancet.com
Portal vein thrombosis (PVT) refers to the development of a non-malignant obstruction of the
portal vein, its branches, its radicles, or a combination. This Review first provides a …

EASL position paper on clinical follow-up after HCV cure

T Reiberger, S Lens, G Cabibbo, P Nahon… - Journal of …, 2024 - Elsevier
Following the advent of direct-acting antivirals (DAAs), hepatitis C virus (HCV) infection can
be cured in almost all infected patients. This has led to a number of clinical questions …

AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis

DE Kaplan, C Ripoll, M Thiele, BE Fortune… - Hepatology, 2024 - journals.lww.com
This Practice Guidance from the American Association for the Study of Liver Disease
(AASLD) intends to coalesce best practice recommendations for the identification of portal …

[HTML][HTML] Dynamics in liver stiffness measurements predict outcomes in advanced chronic liver disease

G Semmler, Z Yang, L Fritz, F Köck, BS Hofer, L Balcar… - Gastroenterology, 2023 - Elsevier
Background & Aims Liver stiffness measurements (LSMs) provide an opportunity to monitor
liver disease progression and regression noninvasively. We aimed to determine the …

AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension

RK Sterling, SK Asrani, D Levine, A Duarte-Rojo… - Hepatology, 2024 - journals.lww.com
Abbreviations: ALD, alcohol-associated liver disease; APRI, aspartate aminotransferase–
platelet ratio index; ARFI, acoustic radiation force impulse; AUROC, area under the receiver …

[HTML][HTML] Noninvasive assessment of hepatic decompensation

M Thiele, S Johansen, M Israelsen, J Trebicka… - Hepatology, 2023 - journals.lww.com
Noninvasive tests (NITs) are used in all aspects of liver disease management. Their most
prominent break-through since the millennium has been in advancing early detection of liver …

Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)

M Mandorfer, E Aigner, M Cejna, A Ferlitsch… - Wiener klinische …, 2023 - Springer
The Billroth IV consensus was developed during a consensus meeting of the Austrian
Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of …

Beta-blockers in the era of precision medicine in patients with cirrhosis

A Albillos, A Krag - Journal of Hepatology, 2023 - Elsevier
For decades, non-selective beta-blockers (NSBBs) have been the standard of care for the
primary and secondary prevention of bleeding from oesophageal varices. However, several …

Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis

J Berenguer, T Aldámiz-Echevarría, V Hontañón… - Hepatology, 2025 - journals.lww.com
Conclusions: Non-liver non-AIDS–related events were the leading causes of morbidity and
mortality after direct-acting antiviral cure among coinfected patients with advanced …

[HTML][HTML] Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII–an update

D Segna, YP Mendoza, NF Lange… - Digestive and liver …, 2023 - Elsevier
Non-invasive tests (NITs) and liver stiffness measurement (LSM) in particular, have entered
clinical practice over 20 years ago as point-of-care tests to diagnose liver fibrosis in patients …